Life ScienceCompany
AstraZeneca M&A Summary
AstraZeneca has acquired 21 companies, including 8 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 11 assets.
AstraZeneca’s largest acquisition to date was in 2020, when it acquired Alexion Pharmaceuticals for $39.0B. It’s largest disclosed sale occurred in 2016, when it sold AstraZeneca - Small Molecule Anti-Infective Business to Pfizer for $550M. AstraZeneca has acquired in 8 different US states, and 8 countries. The Company’s most targeted sectors include life science (90%) and medical products (6%).
AstraZeneca Business Overview
Where is AstraZeneca headquartered?
AstraZeneca is headquartered in Cambridge, United Kingdom.
What is AstraZeneca’s revenue?
AstraZeneca disclosed revenue of 45,811M USD for 2023 and 44,351M USD for 2022.
How many employees does AstraZeneca have?
AstraZeneca has 83,100 employees.
What sector is AstraZeneca in?
AstraZeneca is a life science company.
When was AstraZeneca founded?
AstraZeneca was founded in 1992.
M&A Summary
-
M&A Total Activity30
- M&A Buy Activity19
- M&A Sell Activity11
- Total Sectors Invested 3
- Total Countries Invested 8
- M&A Buy/Sell Connections 19
- M&A Advisors 4
Unlimited Searches
